Stephan Duparc
About
Stephan Duparc is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Stephan Duparc has authored 84 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Public Health, Environmental and Occupational Health, 31 papers in Pharmacology and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephan Duparc's work include Malaria Research and Control (73 papers), Mosquito-borne diseases and control (28 papers) and Drug-Induced Hepatotoxicity and Protection (23 papers). Stephan Duparc is often cited by papers focused on Malaria Research and Control (73 papers), Mosquito-borne diseases and control (28 papers) and Drug-Induced Hepatotoxicity and Protection (23 papers). Stephan Duparc collaborates with scholars based in Switzerland, United Kingdom and United States. Stephan Duparc's co-authors include Isabelle Borghini-Fuhrer, Jörg J. Möhrle, Lawrence Fleckenstein, Timothy N. C. Wells, Jeremy N. Burrows, Ernest Beutler, Fiona Macintyre, Nick Carter, Chang-Sik Shin and Rob Hooft van Huijsduijnen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
In The Last Decade
Stephan Duparc
81 papers receiving 2.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Stephan Duparc Switzerland | 28 | 2.1k | 631 | 566 | 526 | 350 | 84 | 2.9k | ||
| Theonest K. Mutabingwa Tanzania | 34 | 2.9k 1.4× | 423 0.7× | 573 1.0× | 416 0.8× | 307 0.9× | 55 | 3.7k | ||
| Peter Winstanley United Kingdom | 26 | 2.6k 1.2× | 459 0.7× | 400 0.7× | 482 0.9× | 463 1.3× | 54 | 3.2k | ||
| Aung Pyae Phyo Thailand | 29 | 2.9k 1.4× | 905 1.4× | 289 0.5× | 426 0.8× | 346 1.0× | 63 | 3.4k | ||
| Srivicha Krudsood Thailand | 29 | 2.3k 1.1× | 289 0.5× | 289 0.5× | 332 0.6× | 349 1.0× | 118 | 3.1k | ||
| C. Luxemburger Thailand | 26 | 3.2k 1.5× | 660 1.0× | 367 0.6× | 653 1.2× | 353 1.0× | 32 | 3.6k | ||
| S. Looareesuwan Thailand | 29 | 2.7k 1.3× | 544 0.9× | 457 0.8× | 595 1.1× | 303 0.9× | 36 | 3.7k | ||
| Enny Kenangalem Indonesia | 40 | 4.0k 1.9× | 392 0.6× | 428 0.8× | 492 0.9× | 639 1.8× | 109 | 5.2k | ||
| A. Sowunmi Nigeria | 30 | 2.4k 1.1× | 377 0.6× | 298 0.5× | 760 1.4× | 239 0.7× | 134 | 2.8k | ||
| Charles J. Woodrow United Kingdom | 26 | 2.2k 1.0× | 632 1.0× | 137 0.2× | 327 0.6× | 321 0.9× | 66 | 2.8k | ||
| S Looareesuwan Thailand | 32 | 2.6k 1.2× | 433 0.7× | 215 0.4× | 540 1.0× | 311 0.9× | 73 | 3.3k |
Countries citing papers authored by Stephan Duparc
Since
Specialization
Citations
This map shows the geographic impact of Stephan Duparc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Duparc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Duparc more than expected).
Fields of papers citing papers by Stephan Duparc
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Stephan Duparc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Duparc. The network helps show where Stephan Duparc may publish in the future.
Co-authorship network of co-authors of Stephan Duparc
This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Duparc. A scholar is included among the top collaborators of Stephan Duparc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Duparc. Stephan Duparc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Achan, Jane, Aïssata Barry, Didier Leroy, et al.. (2024). Defining the next generation of severe malaria treatment: a target product profile. Malaria Journal. 23(1). 174–174.
2.
Sharma, Raman, Isabelle Borghini-Fuhrer, Gonzalo J. Domingo, et al.. (2024). Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria. Malaria Journal. 23(1). 145–145.
3.
Groger, Mirjam, Serge-Brice Assi, Jude D. Bigoga, et al.. (2023). Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries. International Journal of Infectious Diseases. 137. 114–117.
4.
Tan, Lionel, et al.. (2022). Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review. Infectious Diseases and Therapy. 12(1). 33–51.
5.
Mombo‐Ngoma, Ghyslain, Serge-Brice Assi, Jude D. Bigoga, et al.. (2021). Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study. PLoS Medicine. 18(6). e1003669–e1003669.
6.
Hachizovu, Sebastian, Alieu Mendy, Mamadou Ousmane Ndiath, et al.. (2021). Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial. Clinical Infectious Diseases. 74(2). 180–188.
7.
Funck‐Brentano, Christian, Stephan Duparc, Sodiomon B. Sirima, et al.. (2019). Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method. Scientific Reports. 9(1). 883–883.
8.
Assi, Serge-Brice, et al.. (2017). Sustained Effectiveness of a Fixed-Dose Combination of Artesunate and Amodiaquine in 480 Patients with Uncomplicated Plasmodium falciparum Malaria in Côte d’Ivoire. SHILAP Revista de lepidopterología. 2017. 1–8.
9.
Rueangweerayut, Ronnatrai, Germana Bancone, Andrew P. Beelen, et al.. (2017). Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers. American Journal of Tropical Medicine and Hygiene. 97(3). 702–711.
10.
Leang, Rithea, Sara E. Canavati, Nimol Khim, et al.. (2016). Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia. Antimicrobial Agents and Chemotherapy. 60(7). 3884–3890.
11.
McCarthy, James, Louise Marquart, Silvana Sekuloski, et al.. (2016). Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development. Antimicrobial Agents and Chemotherapy. 60(6). 3669–3675.
12.
Phiri, Kamija S., Joshua Kimani, George Mtove, et al.. (2016). Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. PLoS ONE. 11(11). e0165692–e0165692.
13.
Methaneethorn, Janthima, Michael Ramharter, Abdoulaye Djimdé, et al.. (2015). Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients. Antimicrobial Agents and Chemotherapy. 60(3). 1450–1458.
14.
Llanos‐Cuentas, Alejandro, Marcus Lacerda, Ronnatrai Rueangweerayut, et al.. (2013). Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. The Lancet. 383(9922). 1049–1058.
15.
Pamba, Allan, Nick Carter, Stephan Duparc, et al.. (2012). Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone. Blood. 120(20). 4123–4133.
16.
McCarthy, James, Silvana Sekuloski, Paul Griffin, et al.. (2011). A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs. PLoS ONE. 6(8). e21914–e21914.
17.
Carter, Nick, Allan Pamba, Stephan Duparc, & John Waitumbi. (2011). Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials. Malaria Journal. 10(1). 241–241.
18.
Tiono, Alfred B., Amadou Dıcko, J O Awobusuyi, et al.. (2008). Chlorproguanil-Dapsone-Artesunate Vs. Chlorproguanil-Dapsone: A Randomised, Double-Blind Phase Iii Trial for the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria. LSTM Online Archive (Liverpool School of Tropical Medicine).
19.
Louis, F.J., et al.. (1999). Essai comparatif de l'artéméther et de la quinine dans le paludisme grave a Plasmodium falciparum de l'adulte et du grand enfant au Cameroun. 59(2). 151–156.
20.
Duparc, Stephan, et al.. (1999). [Comparative study of artemether and quinine in severe Plasmodium falciparum malaria in adults and older children in Cameroon].. PubMed. 59(2). 151–6.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Theonest K. Mutabingwa Breakdown of academic impact, for papers by Peter Winstanley Breakdown of academic impact, for papers by Aung Pyae Phyo Breakdown of academic impact, for papers by Srivicha Krudsood Breakdown of academic impact, for papers by C. Luxemburger Breakdown of academic impact, for papers by S. Looareesuwan Breakdown of academic impact, for papers by Enny Kenangalem Breakdown of academic impact, for papers by A. Sowunmi Breakdown of academic impact, for papers by Charles J. Woodrow Breakdown of academic impact, for papers by S Looareesuwan